Business Description
EyeGene Inc
ISIN : KR7185490000
Compare
Compare
Traded in other countries / regions
185490.Korea IPO Date
2015-11-16Description
EyeGene Inc is a South Korea based bio-venture company. It researches and develops biopharmaceuticals. Its products include EG-Mirotin, EG-HPV, EGVac systems. It provides drugs for the treatment of age-related degenerative diseases. Its products target diabetic retinopathy.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 21.76 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.63 | |||||
Beneish M-Score | -1.73 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -13.5 | |||||
3-Year EBITDA Growth Rate | -5 | |||||
3-Year EPS without NRI Growth Rate | 3.7 | |||||
3-Year FCF Growth Rate | -8.5 | |||||
3-Year Book Growth Rate | 40.4 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.49 | |||||
9-Day RSI | 55.9 | |||||
14-Day RSI | 51.69 | |||||
6-1 Month Momentum % | -25.72 | |||||
12-1 Month Momentum % | -26.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.53 | |||||
Quick Ratio | 8.51 | |||||
Cash Ratio | 8.28 | |||||
Days Inventory | 61.94 | |||||
Days Sales Outstanding | 71.14 | |||||
Days Payable | 245.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21 | |||||
Shareholder Yield % | 0.44 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.29 | |||||
Operating Margin % | -782.07 | |||||
Net Margin % | -578.52 | |||||
FCF Margin % | -758.63 | |||||
ROE % | -28.75 | |||||
ROA % | -22.98 | |||||
ROIC % | -95.73 | |||||
ROC (Joel Greenblatt) % | -287.35 | |||||
ROCE % | -35.42 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 22.41 | |||||
PB Ratio | 1.31 | |||||
Price-to-Tangible-Book | 1.34 | |||||
EV-to-EBIT | -1.41 | |||||
EV-to-EBITDA | -1.51 | |||||
EV-to-Revenue | 11.59 | |||||
EV-to-FCF | -1.52 | |||||
Price-to-Net-Current-Asset-Value | 2.27 | |||||
Price-to-Net-Cash | 2.37 | |||||
Earnings Yield (Greenblatt) % | -70.85 | |||||
FCF Yield % | -28.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EyeGene Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 2,870.707 | ||
EPS (TTM) (â‚©) | -749 | ||
Beta | 1.72 | ||
Volatility % | 60.82 | ||
14-Day RSI | 51.69 | ||
14-Day ATR (â‚©) | 120.455938 | ||
20-Day SMA (â‚©) | 2771.75 | ||
12-1 Month Momentum % | -26.58 | ||
52-Week Range (â‚©) | 2430 - 4895 | ||
Shares Outstanding (Mil) | 27.03 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EyeGene Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EyeGene Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
EyeGene Inc Frequently Asked Questions
What is EyeGene Inc(XKRX:185490)'s stock price today?
The current price of XKRX:185490 is â‚©2845.00. The 52 week high of XKRX:185490 is â‚©4895.00 and 52 week low is â‚©2430.00.
When is next earnings date of EyeGene Inc(XKRX:185490)?
The next earnings date of EyeGene Inc(XKRX:185490) is .
Does EyeGene Inc(XKRX:185490) pay dividends? If so, how much?
EyeGene Inc(XKRX:185490) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |